BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 20810382)

  • 1. Lessons learned from genetic testing.
    Esserman L; Kaklamani V
    JAMA; 2010 Sep; 304(9):1011-2. PubMed ID: 20810382
    [No Abstract]   [Full Text] [Related]  

  • 2. Approaching the dilemma between prophylactic bilateral mastectomy or oophorectomy for breast and ovarian cancer prevention in carriers of BRCA1 or BRCA2 mutations.
    Roukos DH; Agnanti NJ; Paraskevaidis E; Kappas AM
    Ann Surg Oncol; 2002 Dec; 9(10):941-3. PubMed ID: 12464584
    [No Abstract]   [Full Text] [Related]  

  • 3. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium.
    Burke W; Daly M; Garber J; Botkin J; Kahn MJ; Lynch P; McTiernan A; Offit K; Perlman J; Petersen G; Thomson E; Varricchio C
    JAMA; 1997 Mar; 277(12):997-1003. PubMed ID: 9091675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Genetic predisposition for breast cancer: BRCA1 and BRCA2 genes].
    Narod SA; Rodríguez AA
    Salud Publica Mex; 2011; 53(5):420-9. PubMed ID: 22218796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using genetic analysis to individualize preventive measures for breast and ovarian cancers.
    Olopade OI
    Nat Clin Pract Oncol; 2006 Apr; 3(4):182-3. PubMed ID: 16596140
    [No Abstract]   [Full Text] [Related]  

  • 6. One risk fits all?
    De Bock GH; Mourits MJ; Oosterwijk JC
    J Clin Oncol; 2007 Aug; 25(22):3383-4; author reply 3384. PubMed ID: 17664491
    [No Abstract]   [Full Text] [Related]  

  • 7. Summaries for patients. Assessing the genetic risk for BRCA-related breast or ovarian cancer in women: recommendations from the U.S. Preventive Services Task Force.
    Ann Intern Med; 2014 Feb; 160(4):I-16. PubMed ID: 25006622
    [No Abstract]   [Full Text] [Related]  

  • 8. BRCA1 and BRCA2 variants of uncertain significance. Part two: medical management.
    Miller-Samuel S; Rosenberg A; Berger A; Gomella L; Loren D; Morris GJ
    Semin Oncol; 2011 Oct; 38(5):605-11. PubMed ID: 21943665
    [No Abstract]   [Full Text] [Related]  

  • 9. The Role of Risk-Reducing Surgery in Hereditary Breast and Ovarian Cancer.
    Hartmann LC; Lindor NM
    N Engl J Med; 2016 Feb; 374(5):454-68. PubMed ID: 26840135
    [No Abstract]   [Full Text] [Related]  

  • 10. Familial breast and ovarian cancer: genetic counseling and clinical management in Italy.
    Pasini B; Pierotti MA
    Dis Markers; 1999 Oct; 15(1-3):41-3. PubMed ID: 10595250
    [No Abstract]   [Full Text] [Related]  

  • 11. Choices--and uncertainties--for women with BRCA mutations.
    Couzin J
    Science; 2003 Oct; 302(5645):592. PubMed ID: 14576419
    [No Abstract]   [Full Text] [Related]  

  • 12. Preventive surgery is associated with reduced cancer risk and mortality in women with BRCA1 and BRCA2 mutations.
    Domchek SM; Rebbeck TR
    LDI Issue Brief; 2010; 16(2):1-4. PubMed ID: 21545057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individualized preventive and therapeutic management of hereditary breast ovarian cancer syndrome.
    Roukos DH; Briasoulis E
    Nat Clin Pract Oncol; 2007 Oct; 4(10):578-90. PubMed ID: 17898808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. JAMA patient page. BRCA genes and breast cancer.
    Pluta RM; Golub RM
    JAMA; 2011 Jun; 305(21):2244. PubMed ID: 21632489
    [No Abstract]   [Full Text] [Related]  

  • 15. Re: Potential for bias in studies on efficacy of prophylactic surgery for BRCA1 and BRCA2 mutation carriers.
    Foulkes WD
    J Natl Cancer Inst; 2003 Sep; 95(17):1344; author reply 1344. PubMed ID: 12953090
    [No Abstract]   [Full Text] [Related]  

  • 16. [Preventive oophorectomy in women exhibiting BRCA mutations].
    Roseau E
    Presse Med; 2003 Feb; 32(4):149-50. PubMed ID: 12613483
    [No Abstract]   [Full Text] [Related]  

  • 17. Prophylactic surgery recommended for BRCA1 carriers.
    Cancer Discov; 2014 May; 4(5):OF1. PubMed ID: 24795013
    [No Abstract]   [Full Text] [Related]  

  • 18. Summaries for patients. Assessing the genetic risk for BRCA-related breast or ovarian cancer in women: recommendations from the U.S. Preventive Services Task Force.
    Ann Intern Med; 2014 Feb; 160(4):I-16. PubMed ID: 24366402
    [No Abstract]   [Full Text] [Related]  

  • 19. Direct to confusion: lessons learned from marketing BRCA testing.
    Matloff E; Caplan A
    Am J Bioeth; 2008 Jun; 8(6):5-8. PubMed ID: 18726769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary breast and ovarian cancer syndrome.
    ACOG Committee on Practice Bulletins
    Gynecol Oncol; 2009 Apr; 113(1):6-11. PubMed ID: 19309638
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.